Biomed Central Ltd

SHERPA: Unknown

People

  1. Vickers
    Vickers
  2. Postow
    Postow
  3. D'Angelo
    D'Angelo
  4. Offit
    Offit
  5. Budhu
    Budhu
  6. Motzer
    Motzer
  7. Cheung
    Cheung
  8. Voss
    Voss
  9. O'Reilly
    O'Reilly
  10. Robson
    Robson

Groups

  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)
  7. Epidemiology and Biostatistics (151)
  8. Melanoma and Immunotherapeutics Service (148)
  9. Survivorship Research (121)
  10. Surgery (118)
Search Within
Formats
  1. Journal Article (745)
  2. Meeting Abstract (257)
  3. Review (40)
  4. Guidelines (20)
  5. Editorial (10)
  6. Research Letter (7)
  7. Correspondence (4)
  8. Conference Paper (1)
  9. Miscellaneous (1)
Groups
  1. Department of Medicine (556)
  2. Solid Tumor Oncology Division (454)
  3. GSK Faculty (290)
  4. Sloan Kettering Institute Postdocs (193)
  5. Population Sciences Research Program (158)
  6. Hematologic Malignancies, Division of (152)

More Groups

People
  1. Jedd Wolchok (83)
  2. Taha Merghoub (55)
  3. Andrew Vickers (44)
  4. Michael Postow (43)
  5. Matthew Hellmann (30)
  6. Roberta Zappasodi (24)

More People

Years
  1. 2025 (28)
  2. 2024 (63)
  3. 2023 (45)
  4. 2022 (123)
  5. 2021 (91)
  6. 2020 (99)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (404)
  2. Breast Cancer Research (67)
  3. BMC Cancer (64)
  4. Genome Biology (46)
  5. Journal of Hematology & Oncology (42)
  6. Journal of Translational Medicine (35)

More Publications

Results (1085)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Efficacy of anti-PD-1 and ipilimumab alone or in combination in acral melanoma
    Journal Article

    Bhave, P.; Ahmed, T.; Lo, S. N.; Shoushtari, A.; Zaremba, A.; Versluis, J. M.; Mangana, J.; Weichenthal, M.; Si, L.; Lesimple, T.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy
    Journal Article

    Hwang, M.; Canzoniero, J. V.; Rosner, S.; Zhang, G.; White, J. R.; Belcaid, Z.; Cherry, C.; Balan, A.; Pereira, G.; Curry, A.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]
    Journal Article

    Goshe, B. M.; Rasmussen, A. W.; Wagner, L. I.; Sicks, J. R. D.; Gareen, I. F.; Carlos, R. C.; Herman, B. A.; Walter, A. W.; Regan, S.; Levy, D. E.; more...
    BMC Public Health (2022)

    Fulltext@MSK | Save
  • Accommodating heterogeneous missing data patterns for prostate cancer risk prediction
    Journal Article

    Neumair, M.; Kattan, M. W.; Freedland, S. J.; Haese, A.; Guerrios-Rivera, L.; De Hoedt, A. M.; Liss, M. A.; Leach, R. J.; Boorjian, S. A.; Cooperberg, M. R.; more...
    BMC Medical Research Methodology (2022)

    Fulltext@MSK | Save
  • Perspectives in immunotherapy: Meeting report from the Immunotherapy Bridge, December 1st–2nd, 2021
    Review

    Ascierto, P. A.; Avallone, A.; Bhardwaj, N.; Bifulco, C.; Bracarda, S.; Brody, J. D.; Buonaguro, L.; Demaria, S.; Emens, L. A.; Ferris, R. L.; more...
    Journal of Translational Medicine (2022)

    Fulltext@MSK | Save
  • Direct oral anticoagulant versus low molecular weight heparin for the treatment of cancer-associated venous thromboembolism: 2022 updated systematic review and meta-analysis of randomized controlled trials
    Research Letter

    Frere, C.; Farge, D.; Schrag, D.; Prata, P. H.; Connors, J. M.
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save
  • Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lung cancer and mesothelioma
    Guidelines

    Govindan, R.; Aggarwal, C.; Antonia, S. J.; Davies, M.; Dubinett, S. M.; Ferris, A.; Forde, P. M.; Garon, E. B.; Goldberg, S. B.; Hassan, R.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Role of tumor infiltrating lymphocytes and spatial immune heterogeneity in sensitivity to PD-1 axis blockers in non-small cell lung cancer
    Journal Article

    Lopez de Rodas, M.; Nagineni, V.; Ravi, A.; Datar, I. J.; Mino-Kenudson, M.; Corredor, G.; Barrera, C.; Behlman, L.; Rimm, D. L.; Herbst, R. S.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Targeting CISH enhances natural cytotoxicity receptor signaling and reduces NK cell exhaustion to improve solid tumor immunity
    Journal Article

    Bernard, P. L.; Delconte, R.; Pastor, S.; Laletin, V.; Costa Da Silva, C.; Goubard, A.; Josselin, E.; Castellano, R.; Krug, A.; Vernerey, J.; more...
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • COVID-19 double jeopardy: The overwhelming impact of the social determinants of health
    Review

    Badalov, E.; Blackler, L.; Scharf, A. E.; Matsoukas, K.; Chawla, S.; Voigt, L. P.; Kuflik, A.
    International Journal for Equity in Health (2022)

    Fulltext@MSK | Save